Inhibitory and preventative effects of processed morinda citrifolia on mutagenesis and carcinogenesis in mammals

A method for inducing antimutagenesis activity within mammals and repairing existing DNA damage, said method comprising the steps of:

• adding a processed Morinda citrifolia product to an alcohol-based solution;
• isolating and extracting an active ingredient of said processed Morinda citrifolia product from said solution;
• introducing, internally, said extracted active ingredient into the body of said mammal, said active ingredient of said Morinda citrifolia functions to inhibit and block DNA adduct formation, thus inducing antimutagenesis activity within said mammal.

A method for inducing antimutagenesis activity within mammals, said method comprising the steps of:

• orally administering at least one ounce of a naturaceutical formulation comprising a processed Morinda citrifolia product on an empty stomach in the morning;
• and
• orally administering to said mammal at least one ounce of said naturaceutical formulation on an empty stomach prior to sleeping at night.

A method for inhibiting and preventing mutagenesis in mammals, said method comprising the steps of:

• orally administering at least one ounce of a naturaceutical formulation comprising a processed Morinda citrifolia product in the morning on an empty stomach;
• orally administering at least one ounce of said naturaceutical formulation prior to sleeping at night;
• repeating said steps of orally administering said naturaceutical for a sustained safe, pre-determined duration of time to effectuate antimutagenesis activity within said mammal.

A method for decreasing oxidative DNA damage, said method comprising the steps of:

• administering a naturaceutical composition to a mammal, said naturaceutical composition comprising:
• at least one processed Morinda citrifolia product present in an amount between about 0.01 and 100 percent by weight.

A method for decreasing the division rate of tumor cells, said method comprising the steps of:

• administering a naturaceutical composition to a mammal, said naturaceutical composition comprising:
• at least one processed Morinda citrifolia product present in an amount between about 0.01 and 100 percent by weight.

The method of claim 53, wherein said processed Morinda citrifolia product is selected from the group consisting of processed Morinda citrifolia fruit juice, processed Morinda citrifolia puree juice, processed Morinda citrifolia dietary fiber, processed Morinda citrifolia oil, and processed Morinda citrifolia oil extract.

A method for inhibiting the drug breakdown functions of cytochrome enzymes for the purpose of facilitating antimutagenesis activity within a mammal, said method comprising the steps of:

• administering an antimutagenesis medication to a patient;
• administering a naturaceutical composition to said patient concurrently with said antimutagenesis medication, said naturaceutical comprising a processed Morinda citrifolia product that increases the efficacy of said antimutagenesis medication by inhibiting the medication breakdown and metabolizing functions of said cytochrome enzymes, said processed Morinda citrifolia product present in an amount by weight between 0.1 and 100 percent.

A naturaceutical composition for inhibiting and preventing mutagenesis and repairing DNA damage in mammals, said naturaceutical composition comprising:

• at least one processed Morinda citrifolia product present in an amount between about 0.01 and 100 percent by weight.

A naturaceutical formulation for effectuating antimutagenesis activity within mammals, said naturaceutical formulation comprising:

• at least one processed Morinda citrifolia product present in an amount by weight between about 0.01 and 100 percent;
• and
• Methyl Sulfonyl methane present in an amount by weight between about 0.01 and 100 percent.